Mouse High Mobility Group Protein 1 (HMGB1) ELISA Kit EKU04790 from Biomatik | Biocompare.com

Supplier Images

Mouse High Mobility Group Protein 1 (HMGB1) ELISA Kit
EKU04790_Image_1.jpg

Typical Standard Curve for HMGB1 ELISA (Sandwich)

Be the first to write a review!

Citations:

Supplier Page from
Biomatik for
Mouse High Mobility Group Protein 1 (HMGB1) ELISA Kit

Description

Mouse High Mobility Group Protein 1 (HMGB1) ELISA Kit for detecting HMGB1 in serum, plasma, other biological fluids

Product Specs
ItemMouse High Mobility Group Protein 1 (HMGB1) ELISA Kit
CompanyBiomatik
Price $881.00Supplier Page View Company Product Page
Catalog NumberEKU04790
Quantity96 Tests
ApplicationsDouble-antibody Sandwich
Detection Range46.88-3,000pg/mL
DetectionColormetric
PrecisionIntra-Assay: CV<10%, Inter-Assay: CV<12%
ReactivityMouse (Mus musculus)
Sample TypeSerum, Plasma, Other Biological Fluids
Sensitivity18.29pg/mL
Volume11, 8, 100ul, 14
Detection TargetHigh Mobility Group Protein 1 (HMGB1)
Assay Time3h
NCBI Full Gene Namehigh mobility group box 1
NCBI Gene Aliasesp30, HMG-1, Hmg1, SBP-1
Storage4°C for one month; Long term: see manual
Research AreaInfection immunity

Add to Compare List

Biomatik

Local Office

Biomatik

105-501 Silverside Road

Wilmington, Delaware 19809

United States

Phone: 1-800-836-8089
Fax: 1-877-221-3515

Company Profile

Website: www.biomatik.com

International Office

Biomatik

4 Third Ave

Kitchener, Ontario N2C 1N6

Canada

Phone: 1-800-836-8089 (USA/Canada)
1-519-489-7195 (International)
Fax: 1-877-221-3515 (USA/Canada)
1-519-231-0140 (International)

Company Profile

Website: www.biomatik.com

(1) The adaptor protein TRAF3 is an immune checkpoint that inhibits myeloid-derived suppressor cell expansionFrontiers in immunologyJanuary 1, 2023Zhu S, Lalani AI, Jin J, Sant'Angelo D, Covey LR, Liu K, Young HA, Ostrand-Rosenberg S, Xie P.

(2) A Novel P53 Nanomedicine Reduces Immunosuppression and Augments Anti-PD-1 Therapy for Non-Small Cell Lung Cancer in Syngeneic Mouse ModelsCellsOctober 31, 2022Kim SS, Harford JB, Moghe M, Doherty C, Chang EH.

(3) Oncolytic vaccinia virus reinvigorates peritoneal immunity and cooperates with immune checkpoint inhibitor to suppress peritoneal carcinomatosis in colon cancerJournal for immunotherapy of cancerNovember 1, 2020Lee YS, Lee WS, Kim CW, Lee SJ, Yang H, Kong SJ, Ning J, Yang KM, Kang B, Kim WR, et al.

Be the First to Write a Review!